Cargando…

Development, Characterization, and Evaluation of SLN-Loaded Thermoresponsive Hydrogel System of Topotecan as Biological Macromolecule for Colorectal Delivery

BACKGROUND: Chemotherapeutic drugs cause severe toxicities if administered unprotected, without proper targeting, and controlled release. In this study, we developed topotecan- (TPT-) loaded solid lipid nanoparticles (SLNs) for their chemotherapeutic effect against colorectal cancer. The TPT-SLNs we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xing, R., Mustapha, O., Ali, T., Rehman, M., Zaidi, S. S., Baseer, A., Batool, S., Mukhtiar, M., Shafique, S., Malik, M., Sohail, S., Ali, Z., Zahid, F., Zeb, A., Shah, F., Yousaf, A., Din, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275402/ https://www.ncbi.nlm.nih.gov/pubmed/34285920 http://dx.doi.org/10.1155/2021/9968602

Ejemplares similares

Preparation of SLN-containing Thermoresponsive In-situ Forming Gel as a Controlled Nanoparticle Delivery System and Investigating its Rheological, Thermal and Erosion Behavior
por: Dorraj, Golnar, et al.
Publicado: (2015)

Spherical inversion on SLn(R)
por: Jorgenson, Jay, et al.
Publicado: (2001)

Macromolecules as targeted drugs delivery vehicles: an overview
por: Ali, Yousaf, et al.
Publicado: (2019)

Screening, selection and development of Bacillus subtilis apr-IBL04 for hyper production of macromolecule alkaline protease
por: Shafique, Tahira, et al.
Publicado: (2021)

PEGylated SLN as a Promising Approach for Lymphatic Delivery of Gefitinib to Lung Cancer
por: Sherif, Abdelrahman Y, et al.
Publicado: (2022)

Chitosan-Coated SLN: A Potential System for Ocular Delivery of Metronidazole
por: Sikhondze, Simise S., et al.
Publicado: (2023)

Photomotion of Hydrogels with Covalently Attached Azo Dye Moieties—Thermoresponsive and Non-Thermoresponsive Gels
por: Jaik, Thorben G., et al.
Publicado: (2022)

Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery
por: Severino, Patrícia, et al.
Publicado: (2012)

Tough, Stretchable, and Thermoresponsive Smart Hydrogels
por: Luo, Yi, et al.
Publicado: (2023)

Optimization of the Conditions of Solid Lipid Nanoparticles (SLN) Synthesis
por: Musielak, Ewelina, et al.
Publicado: (2022)

Topotecan and Cyclophosphamide in Adults with Relapsed Sarcoma
por: Blanchette, P., et al.
Publicado: (2012)

Instantaneous Degelling Thermoresponsive Hydrogel
por: Steinman, Noam Y., et al.
Publicado: (2021)

Increased Therapeutic Efficacy of SLN Containing Etofenamate and Ibuprofen in Topical Treatment of Inflammation
por: Mancini, Giuliana, et al.
Publicado: (2021)

Thermoresponsive Gels
por: Taylor, M. Joan, et al.
Publicado: (2017)

Oral topotecan: bioavailability and effect of food co-administration
por: Herben, V M M, et al.
Publicado: (1999)

Evidence of Th2 polarization of the sentinel lymph node (SLN) in melanoma
por: Grotz, Travis E, et al.
Publicado: (2015)

Nanoengineered thermoresponsive magnetic hydrogels for biomedical applications
por: Jalili, Nima A., et al.
Publicado: (2016)

The development of a solid lipid nanoparticle (SLN)-based lacticin 3147 hydrogel for the treatment of wound infections
por: Ryan, Aoibhín, et al.
Publicado: (2023)

Commentary: Periocular topotecan for retinoblastoma
por: Sharma, Minal, et al.
Publicado: (2018)

Thermoresponsive Magnetic Hydrogels as Theranostic Nanoconstructs
por: Jaiswal, Manish K., et al.
Publicado: (2014)

Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery
por: Souto, Eliana B., et al.
Publicado: (2022)

Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer
por: Riemsma, Rob, et al.
Publicado: (2010)

Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer
por: Wysocki, Piotr J., et al.
Publicado: (2023)

Factors affecting pharmacokinetic variability of oral topotecan: a population analysis
por: Léger, F, et al.
Publicado: (2004)

Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan.
por: Vukovic, V., et al.
Publicado: (1997)

Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells
por: Mengeste, Abel M., et al.
Publicado: (2022)

Functional Thermoresponsive Hydrogel Molecule to Material Design for Biomedical Applications
por: Pardeshi, Sagar, et al.
Publicado: (2022)

Thermoresponsive Polypeptoids
por: Liu, Dandan, et al.
Publicado: (2020)

A phase I and pharmacokinetic study of intraperitoneal topotecan
por: Hofstra, L S, et al.
Publicado: (2001)

Periocular topotecan for vitreous seeds in retinoblastoma
por: Sthapit, Purnima R, et al.
Publicado: (2018)

A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours
por: Penson, R T, et al.
Publicado: (2005)

The Role of Cryotherapy in Vitreous Concentrations of Topotecan Delivered by Episcleral Hydrogel Implant
por: Kodetova, Martina, et al.
Publicado: (2022)

Reply: Axillary recurrences after sentinel node (SLN) biopsy without complete axillary dissection in breast cancer patients
por: Reitsamer, R, et al.
Publicado: (2005)

Axillary recurrences after sentinel node (SLN) biopsy without complete axillary dissection in breast cancer patients
por: Kristen, P, et al.
Publicado: (2005)

Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives
por: Üner, Melike, et al.
Publicado: (2007)

Edible solid lipid nanoparticles (SLN) as carrier system for antioxidants of different lipophilicity
por: Oehlke, Kathleen, et al.
Publicado: (2017)

The Lipophilic Purine Nucleoside—Tdp1 Inhibitor—Enhances DNA Damage Induced by Topotecan In Vitro and Potentiates the Antitumor Effect of Topotecan In Vivo
por: Chernyshova, Irina A., et al.
Publicado: (2022)

Successful local regional therapy with topotecan of intraperitoneally growing human ovarian carcinoma xenografts.
por: Pratesi, G., et al.
Publicado: (1995)

Nanoplatform for the Delivery of Topotecan in the Cancer Milieu: An Appraisal of its Therapeutic Efficacy
por: Alshammari, Mohammed Kanan, et al.
Publicado: (2022)

Phase I and pharmacological study of sequential intravenous topotecan and oral etoposide.
por: Herben, V. M., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_k2luumva5tdo2n3hf2ti9vbagk